Premaitha Health (NIPT)

 

Latest News

Premaitha Health adds laboratories in Europe

Premaitha Health said it has expanded its European customer base with the addition of four new laboratories. They would...

Premaitha secures four further laboratories in EU

RNS Number: 8857Y Premaitha Health PLC 11 December 2017 Premaitha Health PLC (" Premaitha " or the "Company " ) Premaitha secures four further laboratories in Europe Manchester, UK - 11 December 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing (NIPT), announces fu...

Premaitha CEO Wins Outstanding Contribution Award

RNS Number: 1260Y Premaitha Health PLC 01 December 2017 Premaitha CEO Wins Bionow Outstanding Contribution Award Manchester, UK - 1 December 2017: Premaitha Health PLC ( AIM: NIPT ) , a leading international molecular diagnostics group focused on non-invasive prenatal testing (NIPT), is proud to announce that its CEO, Dr Stephen Little, last night r...

Premaitha Health opening four new Middle East labs

Premaitha Health said it will open four new laboratories in the Middle East for customers seeking to offer its test for Dow...

All News

DateHeadlineSource
11-12-17Premaitha Health adds laboratories in EuropeStockMarketWire
11-12-17Premaitha secures four further laboratories in EURNS
01-12-17Premaitha CEO Wins Outstanding Contribution AwardRNS
27-11-17Premaitha Health opening four new Middle East labsStockMarketWire
27-11-17Middle East laboratory network expansionRNS
23-11-17Premaitha signs NIPT partner in East AsiaStockMarketWire
23-11-17Premaitha signs new partner in East AsiaRNS
21-11-17Premaitha updates on patent disputesStockMarketWire
21-11-17Litigation First Instance JudgmentRNS
30-10-17Grant of Share OptionsRNS
24-10-17Result of AGMRNS
24-10-17Premaitha expects dispute ruling by year endStockMarketWire
24-10-17AGM StatementRNS
13-10-17Premaitha Health expands in Middle EastStockMarketWire
13-10-17Middle East UpdateRNS
29-09-17Final ResultsRNS
29-09-17Notice of AGMRNS
21-09-17Holding(s) in CompanyRNS
19-09-17Premaitha to offer NIPT in South AfricaRNS
07-09-17Further Patent Infringement ClaimsRNS
29-08-17Premaitha's Down's syndrome test approved in BrazilStockMarketWire
29-08-17Approved for Good Manufacturing Process in BrazilRNS
18-07-17Holding(s) in CompanyRNS
12-07-17Premaitha Health extends Thermo Fisher Scientific agreementStockMarketWire
12-07-17Investment Agreement Extension with Thermo FisherRNS
10-07-17Premaitha announces two laboratory hub contractsStockMarketWire
10-07-17Premaitha announces two laboratory hub contractsRNS
03-07-17Litigation UpdateRNS
27-06-17Holding(s) in CompanyRNS
16-06-17Premaitha launches Sage NIPT solution in Hong KongStockMarketWire
16-06-17Premaitha launches Sage NIPT solutionRNS
05-06-17Premaitha Health issues India business updateStockMarketWire
05-06-17India Business UpdateRNS
26-05-17IONA test validation on Thermo Fisher's Ion S5RNS
19-05-17Premaitha welcomes NIPT recommendation in FranceRNS
16-05-17Prmaitha Health says FY revenues up 24%StockMarketWire
16-05-17Year End Trading UpdateRNS
12-05-17Premaitha updates on Swiss customerStockMarketWire
12-05-17Update Re. Swiss CustomerRNS
03-04-17Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:NIPT Editorial
  • Regulatory news feed for LSE:NIPT Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account